News on Amarin Corporation plc from BioPortfolio.com http://www.BioPortfolio.com Consolidated Amarin Corporation plc news from BioPortfolio.com Wed, 10 Feb 2010 11:20:43 GMT en Amarin To Present at the 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002799&HITNO=0&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002799&THISHREF=http://c.moreover.com/click/here.pl%3fz2519180707%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002799&HITNO=0&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002799&THISHREF=http://c.moreover.com/click/here.pl%3fz2519180707%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Amarin To Present at the 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999299&HITNO=1&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999299&THISHREF=http://c.moreover.com/click/here.pl%3fz2517407872%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999299&HITNO=1&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999299&THISHREF=http://c.moreover.com/click/here.pl%3fz2517407872%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Amarin To Present at the 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998520&HITNO=2&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998520&THISHREF=http://c.moreover.com/click/here.pl%3fz2517102970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998520&HITNO=2&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998520&THISHREF=http://c.moreover.com/click/here.pl%3fz2517102970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Amarin Provides 2009 Year-end Review To Shareholdershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981437&HITNO=3&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981437&THISHREF=http://c.moreover.com/click/here.pl%3fz2506986544%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981437&HITNO=3&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981437&THISHREF=http://c.moreover.com/click/here.pl%3fz2506986544%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Mystic's Amarin looking for major drug partner [The Day, New London, Conn.]http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981626&HITNO=4&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981626&THISHREF=http://c.moreover.com/click/here.pl%3fz2507103493%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981626&HITNO=4&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981626&THISHREF=http://c.moreover.com/click/here.pl%3fz2507103493%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Amarin Provides 2009 Year-End Review to Shareholdershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976570&HITNO=5&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976570&THISHREF=http://c.moreover.com/click/here.pl%3fz2504421914%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976570&HITNO=5&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976570&THISHREF=http://c.moreover.com/click/here.pl%3fz2504421914%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Amarin Provides 2009 Year-End Review to Shareholdershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978032&HITNO=6&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978032&THISHREF=http://c.moreover.com/click/here.pl%3fz2505069470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978032&HITNO=6&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978032&THISHREF=http://c.moreover.com/click/here.pl%3fz2505069470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Amarin Provides 2009 Year-End Review to Shareholdershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974661&HITNO=7&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974661&THISHREF=http://c.moreover.com/click/here.pl%3fz2503647696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974661&HITNO=7&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974661&THISHREF=http://c.moreover.com/click/here.pl%3fz2503647696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyondhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974526&HITNO=8&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974526&THISHREF=http://c.moreover.com/click/here.pl%3fz2503555560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974526&HITNO=8&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974526&THISHREF=http://c.moreover.com/click/here.pl%3fz2503555560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Amarin Provides 2009 Year-End Review to Shareholdershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975809&HITNO=9&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975809&THISHREF=http://c.moreover.com/click/here.pl%3fz2504162478%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975809&HITNO=9&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975809&THISHREF=http://c.moreover.com/click/here.pl%3fz2504162478%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Amarin Corp starts enrolment for Marine & Anchor phase-3 trials of AMR101http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923052&HITNO=10&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923052&THISHREF=http://c.moreover.com/click/here.pl%3fz2476372827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923052&HITNO=10&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923052&THISHREF=http://c.moreover.com/click/here.pl%3fz2476372827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Amarin Enrolls First Patients In Marine, Anchor Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912454&HITNO=11&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912454&THISHREF=http://c.moreover.com/click/here.pl%3fz2470222339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912454&HITNO=11&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912454&THISHREF=http://c.moreover.com/click/here.pl%3fz2470222339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Business Review: Amarin begins Marine & Anchor phase-3 trial for AMR101 to treat cardiovascular diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3900059&HITNO=12&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3900059&THISHREF=http://c.moreover.com/click/here.pl%3fz2463704351%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3900059&HITNO=12&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3900059&THISHREF=http://c.moreover.com/click/here.pl%3fz2463704351%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Joseph Zakrzewski, executive chairman, Amarinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898897&HITNO=13&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898897&THISHREF=http://c.moreover.com/click/here.pl%3fz2463053789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898897&HITNO=13&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898897&THISHREF=http://c.moreover.com/click/here.pl%3fz2463053789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: Medical News: Amarin Corporation Announces First Patients Enrolled In Two Phase 3 Clinical Trials Assessing AMR101 For The Treatment Of Cardiovascular Diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893557&HITNO=14&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893557&THISHREF=http://c.moreover.com/click/here.pl%3fz2460639429%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893557&HITNO=14&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amarin%20Corporation%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893557&THISHREF=http://c.moreover.com/click/here.pl%3fz2460639429%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: